The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa

General Info

Geography

Nigeria (NGA)

South Africa (ZAF)

Coverage type

Country

Time period covered

January, 2011 - December, 2012

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS, HIV transmission, Health care costs, Health care economics, Health care expenditures

Citation

Authors

Schneider K, Nwizu C, Kaplan R, Anderson J, Wilson DP, Emery S, Cooper DA, Boyd MA

Journal

PLoS One

Pages

e54435

Publication year

2013

Suggested citation

Schneider K, Nwizu C, Kaplan R, Anderson J, Wilson DP, Emery S, Cooper DA, Boyd MA. The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa. PLoS One. 2013; 8(2): e54435.